DENTSPLY SIRONA Inc. (XRAY) — Fair Value Analysis

Base-case fair value (P50): $18.62 · Current price: $10.20 · Verdict: Undervalued

The Verdict on XRAY

Based on our proprietary Monte Carlo simulations, DENTSPLY SIRONA INC (XRAY) appears Deeply Undervalued. Our analysis indicates a median fair value (P50) of $18.62, standing significantly above XRAY's current trading price of $10.20. This valuation suggests a substantial +82.5% potential relative to current levels, signaling a compelling opportunity identified through thousands of forward-looking scenarios. The comprehensive Monte Carlo modeling points to a robust expectation of upside, moving beyond simple single-point estimates.

How XRAY stacks up against peers

Despite its "average" quality tier, reflecting operational and financial health against its sector, XRAY's valuation discrepancy is pronounced. The average quality tier suggests that while XRAY exhibits typical industry performance metrics, the market's current pricing of $10.20 disproportionately undervalues its intrinsic worth as determined by our simulations. The identified +82.5% from the P50 fair value of $18.62 underscores the potential for appreciation, even for a company with an average quality profile.

What this means for investors

For investors, the Deeply Undervalued verdict on XRAY, with its median fair value of $18.62 far exceeding $10.20, presents a notable divergence between market price and calculated intrinsic value. While the quality tier is average, the considerable +82.5% identified through Monte Carlo simulations suggests the current market price does not fully reflect XRAY's long-term potential. Understanding the full range of potential outcomes, including both downside scenarios and bull cases, is crucial. Sign up for a free FairCurve account to see the full bear/bull distribution and track XRAY's fair value as new fundamentals are released.